{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:27:13Z","timestamp":1760171233104,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Treatment for coronavirus disease 2019 (COVID-19) pneumonia remains largely supportive till date and multiple clinical trials took place within the short span of time to evaluate the role of investigational therapies. The anti-inflammatory effect of low dose whole lung radiation in treating pneumonia has been documented earlier. This clinical trial analyzed the effect of low dose radiation therapy (LDRT) in a moderately affected COVID-19 pneumonia patient cohort and has evaluated its effect in stopping the conversion of moderate disease into severe disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with moderate COVID-19 pneumonia as characterized by the Ministry of Health and Family Welfare (MOHFW), Government of India, were randomized (1:1) to low dose whole lung radiation versus no radiation. All treatment of patients was concurrently being given as per institutional protocol. Patients were followed up with clinical and laboratory parameters monitored on Days 1, 3, 7, and 14. Computed tomography scan (CT scan) of thorax was performed on Days 1 and 7. Patients were evaluated for conversion of moderate into severe disease as per National Early Warning Score-2 (NEWS-2 score) as the primary end point. The secondary endpoints included changes in ratio between peripheral capillary oxygen saturation and fraction of inspired oxygen (SpO2\/FiO2), biochemical markers, 25-point CT severity score, and radiation induced acute pulmonary toxicities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>At the interim analysis, there were seven patients in the radiation arm and six in the control. A whole lung LDRT improved the outcome of SpO2\/FiO2 at Day 3; however it did not convert into a statistically significant improvement for the NEWS-2 score. The serum levels of LDH, CRP, Ferritin and D-dimer were significantly reduced on 14 days in the LDRT arm in comparison to the baseline value but were not significant between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>LDRT seems to have the potential to prevent moderate COVID-19 pneumonia from a deteriorating to severe category. However, further randomized clinical trial with an adequate number of such patients is warranted to establish the definitive role of LDRT in the management of COVID-19 pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Funding<\/jats:title><jats:p>An intramural research project bearing code: I-27\/621, was sanctioned from the All India Institute of Medical Sciences, Patna, India.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p>Clinical Trials Registry-India (CTRI\/2021\/06\/033912, 25th May 2021) <jats:uri>ctri.nic.in\/Clinicaltrials\/login.php<\/jats:uri><\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.822902","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:25:50Z","timestamp":1648617950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Pritanjali","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avik","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarjeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deependra Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divendu","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkaprava","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijit","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Thovarayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindya Kumar","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samyak","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajhans","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Kakoty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bithika","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2004500","article-title":"Covid-19 in Critically Ill Patients in the Seattle Region \u2014 Case Series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2020-042943","article-title":"Clinical Course and Outcome of Patients With COVID-19 in Mumbai City: An Observational Study","volume":"11","author":"de Souza","year":"2021","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2021.100859","article-title":"Variability in COVID-19 in-Hospital Mortality Rates Between National Health Service Trusts and Regions in England: A National Observational Study for the Getting It Right First Time Programme","volume":"35","author":"Gray","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B5","unstructured":"WHO Recommends Against the Use of Remdesivir in COVID-19 Patients"},{"key":"B6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMOA2023184","article-title":"Repurposed Antiviral Drugs for Covid-19 \u2014 Interim WHO Solidarity Trial Results","volume":"384","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13049-020-00764-3","article-title":"National Early Warning Score 2 (NEWS2) on Admission Predicts Severe Disease and in-Hospital Mortality From Covid-19 - a Prospective Cohort Study","volume":"28","author":"Myrstad","year":"2020","journal-title":"Scand J Trauma Resusc Emergency Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-020-01893-3","article-title":"Evaluation and Improvement of the National Early Warning Score (NEWS2) for COVID-19: A Multi-Hospital Study","volume":"19","author":"Carr","year":"2021","journal-title":"BMC Med"},{"volume-title":"Common Terminology Criteria for Adverse Events:(CTCAE). V5","year":"2017","key":"B9"},{"key":"B10","unstructured":""},{"key":"B11","unstructured":""},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/028418512800900201","article-title":"Die R\u00f6ntgenbestrahlung Akuter und Subakuter Eitriger Entz\u00fcndungen","volume":"9","author":"Fried","year":"2016","journal-title":"Acta Radiologica"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1148\/33.3.331","article-title":"X-Ray Therapy in the Treatment of Acute Pneumonial","volume":"33","author":"Scott","year":"1939","journal-title":"Radiology"},{"key":"B14","first-page":"555","article-title":"How Radiotherapy Was Historically Used To Treat Pneumonia: Could It Be Useful Today","volume":"86","author":"Calabrese","year":"2013","journal-title":"Yale J Biol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/J.IJROBP.2020.07.026","article-title":"Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results","volume":"108","author":"Ameri","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2020.11.049","article-title":"Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report","volume":"109","author":"Sanmamed","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.33130","article-title":"Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia: Planned Day 7 Interim Analysis of a Registered Clinical Trial","volume":"126","author":"Hess","year":"2020","journal-title":"Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult Haemophagocytic Syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2020.04.006","article-title":"Low Dose Lung Radiotherapy for COVID-19 Pneumonia. The Rationale for a Cost-Effective Anti-Inflammatory Treatment","volume":"23","author":"Lara","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20210187","DOI":"10.1259\/bjr.20210187","article-title":"Low Dose Radiation Therapy for COVID-19 Pneumonia: A Pilot Study","volume":"94","author":"Sharma","year":"2021","journal-title":"Br J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.12.024","article-title":"Whole Lung Irradiation as a Novel Treatment for COVID-19: Final Results of the Prospective Randomized Trial (WINCOVID Trial)","volume":"167","author":"Ganesan","year":"2021","journal-title":"Radiother Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1274e1282","DOI":"10.1016\/j.ijrobp.2021.04.029","article-title":"Low Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study","volume":"110","author":"Papachristofilou","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.09.051","article-title":"Low Dose Radiation Therapy for COVID-19: Effective Dose and Estimation of Cancer Risk","volume":"153","author":"Garc\u00eda-Hern\u00e1ndez","year":"2020","journal-title":"Radiother Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of Ischemic Heart Disease in Women After Radiotherapy for Breast Cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.617302","article-title":"Rad1iation-Induced Lymphopenia Beyond the COVID-19 Pandemic","volume":"10","author":"Iorio","year":"2020","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.822902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:25:57Z","timestamp":1648617957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.822902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":27,"alternative-id":["10.3389\/fonc.2022.822902"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.822902","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"article-number":"822902"}}